financetom
Business
financetom
/
Business
/
Boeing Reports $6B Q3 Loss: 'This Is The Bottom,' Says Analyst
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing Reports $6B Q3 Loss: 'This Is The Bottom,' Says Analyst
Nov 3, 2024 11:13 AM

Troubled aerospace giant Boeing Co. ( BA ) reported a $6 billion third-quarter loss on Wednesday, the company's largest since 2020, amid an ongoing labor strike and a company-wide turnaround effort. Analysts weighed in on the company's issues and what is next for Boeing. 

The Details: BofA Securities analyst Ronald Epstein pointed to Boeing ( BA ) stock's muted reaction to the company's earnings report as capturing investor sentiments of "1) This is the bottom and 2) There are plenty more skeletons in the closet for Kelly [Ortberg] to find."

The research firm said the most critical first step to make Boeing ( BA ) "great again" is ending the labor strike. The firm estimates the strike is costing Boeing ( BA ) approximately $50 million a day due to the halt in production and said a strike lasting 58 days would result in a financial impact of nearly $3 billion to the company. 

BofA analysts also see shoring up the balance sheet as key to Boeing's ( BA ) return to glory and now expects the company to raise between $18 billion and $20 billion through its recent mixed shelf offering. 

Boeing ( BA ) reported it is considering divesting non-core assets which BofA views as a good step towards the company reducing debt and strengthening its balance sheet. 

"We see this as a positive not only for offsetting cash-burn but for Boeing ( BA ) to refocus while transforming," the analyst wrote. 

BofA Securities maintained its Neutral rating and $170 price target on Boeing ( BA ) shares. 

Read Next: Bank Of America CEO Cautions Fed Not To ‘Go Too Fast Or Too Slow’ On Interest Rate Cuts

RBC Capital Markets analyst Ken Herbert pointed to Boeing's ( BA ) 2025 negative free cash flow forecast as the focus of the earnings call. The RBC analyst adjusted the firm's estimate to approximately negative $8 billion in 2025 and negative $2.6 billion in 2026 as Boeing ( BA ) indicated a return to positive free cash flow in the second half of 2026. 

Herbert noted CEO Ortberg's initial public comments were "very cautious" during Boeing's ( BA ) earnings call and expressed concerns that investors were looking for more clarity and specific timelines for a return to pre-strike production levels. However, the analyst said he remains optimistic Ortberg can right the ship at Boeing. 

RBC Capital reiterated its Outperform rating and $200 price target on Boeing ( BA ). 

BA Price Action: According to Benzinga Pro, Boeing ( BA ) shares ended Thursday’s session 1.18% lower at $155.20.

Read Also: 

Lucid CEO Peter Rawlinson Talks Saudi Investment, Elon Musk’s Political Views And Taking Business From Tesla

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Dec 11, 2024
09:39 AM EST, 12/11/2024 (MT Newswires) -- Evergold ( EVGUF ) on Wednesday announced assay results for two core holes (DEM24-04 and DEM24-05) completed on the DEM Mountain Zone near Fort St. James, B.C. in early Oct., in follow up to highly encouraging results from an initial 3-hole drill program (DEM23-01,02,03), carried out in fall 2023. The company said the...
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Dec 11, 2024
09:34 AM EST, 12/11/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Wednesday it has bought Georgia-based employee benefits brokerage firm Sheila J. Butler & Co. Financial terms weren't disclosed. Price: 284.17, Change: +0.43, Percent Change: +0.15 ...
AbbVie Closes Aliada Therapeutics Acquisition
AbbVie Closes Aliada Therapeutics Acquisition
Dec 11, 2024
09:37 AM EST, 12/11/2024 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday it has closed the acquisition of Aliada Therapeutics. The company in October agreed to acquire Aliada Therapeutics for $1.40 billion in cash. Price: 174.85, Change: -0.82, Percent Change: -0.47 ...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved